Matches in Wikidata for { <http://www.wikidata.org/entity/Q90390037> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q90390037 description "article scientifique publié en 2018" @default.
- Q90390037 description "artículu científicu espublizáu n'agostu de 2018" @default.
- Q90390037 description "scientific article published on 17 August 2018" @default.
- Q90390037 description "wetenschappelijk artikel" @default.
- Q90390037 description "наукова стаття, опублікована в серпні 2018" @default.
- Q90390037 description "գիտական հոդված հրատարակված 2018 թվականի օգոստոսի 17-ին" @default.
- Q90390037 name "Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer" @default.
- Q90390037 name "Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer" @default.
- Q90390037 type Item @default.
- Q90390037 label "Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer" @default.
- Q90390037 label "Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer" @default.
- Q90390037 prefLabel "Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer" @default.
- Q90390037 prefLabel "Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer" @default.
- Q90390037 P1433 Q90390037-DB2BB2A6-244A-4D3B-AC1A-04EBC208E518 @default.
- Q90390037 P1476 Q90390037-983AB969-A5D7-48C0-860D-FDF761194AF9 @default.
- Q90390037 P2093 Q90390037-01B77429-CB5B-4338-B344-3E8D6A918601 @default.
- Q90390037 P2093 Q90390037-1EFD2149-DF1A-4198-B4DE-3FA7A6412392 @default.
- Q90390037 P2093 Q90390037-234C3CEF-4D85-4978-BEE3-4FE77E24271B @default.
- Q90390037 P2093 Q90390037-2E2045F6-6867-4F2C-8507-8ACD19CC3B05 @default.
- Q90390037 P2093 Q90390037-40B5F955-ED86-4231-ACAD-9229FF6E6C76 @default.
- Q90390037 P2093 Q90390037-48962575-8ACC-4856-9446-3BAC54FC775E @default.
- Q90390037 P2093 Q90390037-5DCEA4CB-4D70-4670-97FF-F8BE6BF69C84 @default.
- Q90390037 P2093 Q90390037-7C50BB75-7078-49BE-8185-BF7672E856A5 @default.
- Q90390037 P2093 Q90390037-944BD08B-0F09-4E12-8916-0C69E8CB2ACD @default.
- Q90390037 P2093 Q90390037-A21D2DC7-125D-4DC2-9325-4C7D37E7C788 @default.
- Q90390037 P2093 Q90390037-AFDD005D-E63F-40B8-9A70-126A6DF58105 @default.
- Q90390037 P2093 Q90390037-B863C314-98B6-4BD2-B498-5E2EDF0C0A4F @default.
- Q90390037 P2093 Q90390037-E24E672C-D661-4F24-A68A-5685318C44BD @default.
- Q90390037 P304 Q90390037-3CD29EF8-3F30-4C5F-AD20-55E168AB65E6 @default.
- Q90390037 P31 Q90390037-16980667-04A5-4F36-80E3-30794C669543 @default.
- Q90390037 P356 Q90390037-877AB572-7D90-4F13-BBB2-88341DAABBAB @default.
- Q90390037 P433 Q90390037-EBAC1C2B-2F3F-4521-9081-24BEE381C6B7 @default.
- Q90390037 P478 Q90390037-2077C7AC-12D5-49DC-8C99-80276FADC91F @default.
- Q90390037 P577 Q90390037-7CC30E88-3328-40ED-9992-EF1DFAE9BFF6 @default.
- Q90390037 P698 Q90390037-41720FFF-8336-40C9-AC07-0F4009BB955F @default.
- Q90390037 P921 Q90390037-D70BB3E6-A3B3-4B41-9AAA-164CFA7A10CE @default.
- Q90390037 P356 03007995.2018.1503484 @default.
- Q90390037 P698 30032697 @default.
- Q90390037 P1433 Q5195063 @default.
- Q90390037 P1476 "Budget impact of including ribociclib in combination with letrozole on US payer formulary: first-line treatment of post-menopausal women with HR+/HER2- advanced or metastatic breast cancer" @default.
- Q90390037 P2093 "Anand A Dalal" @default.
- Q90390037 P2093 "Derek Tang" @default.
- Q90390037 P2093 "Devarshi Bhattacharyya" @default.
- Q90390037 P2093 "Diana Brixner" @default.
- Q90390037 P2093 "Dinesh Mishra" @default.
- Q90390037 P2093 "Gary Oderda" @default.
- Q90390037 P2093 "Gaurav Suri" @default.
- Q90390037 P2093 "Jessica R May" @default.
- Q90390037 P2093 "Joseph Biskupiak" @default.
- Q90390037 P2093 "Kate Young" @default.
- Q90390037 P2093 "Robert Hettle" @default.
- Q90390037 P2093 "Rohit Mistry" @default.
- Q90390037 P2093 "Subrata Bhattacharyya" @default.
- Q90390037 P304 "2143-2150" @default.
- Q90390037 P31 Q13442814 @default.
- Q90390037 P356 "10.1080/03007995.2018.1503484" @default.
- Q90390037 P433 "12" @default.
- Q90390037 P478 "34" @default.
- Q90390037 P577 "2018-08-17T00:00:00Z" @default.
- Q90390037 P698 "30032697" @default.
- Q90390037 P921 Q12859063 @default.